An imbalance between cd36 and abca1 protein expression favors lipid accumulation in stroke-prone ulcerated carotid plaques

Stroke

Volumn 41, Issue 2, 2010, Pages 389-393

  Isoviita, Pia M ^a   Nuotio, Krista ^a,b,c   Saksi, Jani ^a   Turunen, Riitta ^a   Ijäs, Petra ^a,b,c   Pitkäniemi, Janne ^d   Soinne, Lauri ^a,b,c   Kaste, Markku ^c   Kovanen, Petri T ^d   Lindsberg, Perttu J ^a,b,c  

^a BIOMEDICUM HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Foam cell formation; Immunohistochemistry; Lipid transport

Indexed keywords

ABC TRANSPORTER A1; CD36 ANTIGEN; ABC TRANSPORTER; BIOLOGICAL MARKER;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; ERYTHROCYTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROKE; ULCEROGENESIS; VASCULAR NECROSIS; AGED; BLOOD; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; FEMALE; INTIMA; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; UPREGULATION;

AGED; ANTIGENS, CD36; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID STENOSIS; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; LIPID METABOLISM DISORDERS; MALE; MIDDLE AGED; STROKE; TUNICA INTIMA; UP-REGULATION;

EID: 77449100141     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.567636     Document Type: Article

References (15)

1. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metabolism. 2006;4:211-221.
2. Chawla A, Boisvert W, Lee C, Laffitte B, Barak Y, Joseph S, Liao D, Nagy L, Edwards P, Curtiss L, Evans R, Tontonoz P. A PPARgamma-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis. Mol Cell. 2001;7:161-171.
3. Oram JF, Heinecke JW. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev. 2005;85:1343-1372.
4. Nuotio K, Isoviita PM, Saksi J, Ijas P, Pitkaniemi J, Sonninen R, Soinne L, Saimanen E, Salonen O, Kovanen PT, Kaste M, Lindsberg PJ. Adi-pophilin expression is increased in symptomatic carotid atherosclerosis: Correlation with red blood cells and cholesterol crystals. Stroke. 2007; 38:1791-1798.
5. Ijäs P, Nuotio K, Saksi J, Soinne L, Saimanen E, Karjalainen-Lindsberg M, Salonen O, Sarna S, Tuimala J, Kovanen P, Kaste M, Lindsberg P. Microarray analysis reveals overexpression of CD163 and HO-1 in symptomatic carotid plaques. Arterioscler Thromb Vasc Biol. 2007;27: 154-160.
6. Nuotio K, Mäyränpää MI, Saksi J, Ijäs P, Sairanen T, Carpén O, Soinne L, Saimanen E, Salonen O, Lepäntalo M, Kovanen PT, Kaste M, Lindsberg PJ. Endothelial apoptosis does not determine symptom status in carotid artery disease. Cerebrovascular Dis. 2007;23:27-34.
7. Nuotio K, Lindsberg P, Carpén O, Soinne L, Lehtonen-Smeds E, Saimanen E, Lassila R, Sairanen T, Sarna S, Salonen O, Kovanen P, Kaste M. Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis. Neurology. 2003;60:1890-1899.
8. Lehtonen-Smeds EMP, Mäyränpää M, Lindsberg PJ, Soinne L, Saimanen E, Järvinen AAJ, Salonen O, Carpén O, Lassila R, Sarna S, Kaste M, Kovanen PT. Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and symptomatic carotid artery disease. Cerebrovascular Dis. 2005;19:291-301.
9. Kockx M, Cromheeke K, Knaapen M, Bosmans J, De Meyer G, Herman A, Bult H. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:440-446.
10. Wellington C, Walker E, Suarez A, Kwok A, Bissada N, Singaraja R, Yang Y, Zhang L, James E, Wilson J, Francone O, McManus B, Hayden M. ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation. Lab Invest. 2002;82:273-283.
11. Nagy L, Tontonoz P, Alvarez J, Chen H, Evans R. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 1998;93:229-240.
12. Handberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sorensen K, Russell D, Dahl A, Ueland T, Oie E, Aukrust P, Halvorsen B. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability. Stroke. 2008;39: 3092-3095.
13. Han J, Hajjar D, Febbraio M, Nicholson A. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem. 1997;272:21654-21659.
14. Ball R, Stowers E, Burton J, Cary N, Skepper J, Mitchinson M. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. 1995;114:45-54.
15. Yao PM, Tabas I. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J Biol Chem. 2000;275:23807-23813.